Michael C. Skaff

CIK: 0002074003

Transaction Breakdown

Open Market Buys (P)5 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VVOS

Vivos Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (5 total)

VVOS
Vivos Therapeutics, Inc.
Jun 30, 2026
Purchase(P)
Series A Convertible Preferred Stock
Indirect
859.2K shares at avg. $0.58-
VVOS
Vivos Therapeutics, Inc.
Jun 30, 2026
Purchase(P)
Series A Convertible Preferred Stock
Indirect
1.9M shares at avg. $0.58-
VVOS
Vivos Therapeutics, Inc.
Jun 30, 2026
Purchase(P)
Common Stock Purchase Warrant
Indirect
2.7M shares at avg. $0.58-
VVOS
Vivos Therapeutics, Inc.
Mar 31, 2026
Purchase(P)
Indirect
1M shares at avg. $1.34$1.4M
VVOS
Vivos Therapeutics, Inc.
Mar 31, 2026
Purchase(P)
Indirect
308.8K shares at avg. $1.34$414K

		Type	Shares	Price		Ownership
Jun 30, 2026	VVOS Vivos Therapeutics, Inc.	Purchase(P) Series A Convertible Preferred Stock	859,166	$0.58	-	Indirect
Jun 30, 2026	VVOS Vivos Therapeutics, Inc.	Purchase(P) Series A Convertible Preferred Stock	1,890,164	$0.58	-	Indirect
Jun 30, 2026	VVOS Vivos Therapeutics, Inc.	Purchase(P) Common Stock Purchase Warrant	2,749,330	$0.58	-	Indirect
Mar 31, 2026	VVOS Vivos Therapeutics, Inc.	Purchase(P)	1,044,777	$1.34	$1,400,001	Indirect
Mar 31, 2026	VVOS Vivos Therapeutics, Inc.	Purchase(P)	308,848	$1.34	$413,856	Indirect

1-5 of 5 transactions

About Skaff Michael C

Skaff Michael C (SEC CIK 0002074003) files insider reports with the SEC as 10% Owner of Vivos Therapeutics, Inc. (VVOS).

Signal8 holds 3 ownership filings by Skaff Michael C (1 Form 3, 2 Form 4), filed between Jun 20, 2025 and Jul 15, 2026. Those filings report 5 transactions, from Mar 31, 2026 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Skaff Michael C's filings is in GROSSE POINTE, MI.

Recent filings by Skaff Michael C

Jun 30, 2026: Open-market purchases of VVOS derivative securities (3 lines, Form 4, code P).
Mar 31, 2026: Open-market purchases of VVOS shares (2 lines, Form 4, code P).

Other insiders filing for Vivos Therapeutics, Inc. (VVOS)

Krammer Anja B, Director
Lindsay Mark F., Director
Green Ralph Elias, Director
SOKOLOW LEONARD J, Director
JOHNSON GREGG C, Director
Huntsman Ronald Kirk, Chief Executive Officer

How to read Form 4 transaction codes